Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Development of Churg-Strauss syndrome with controlled asthma during omalizumab treatment.

× No keyword cloud information.

7 in total

Review 1. Off-Label Uses of Omalizumab.

Authors: David El-Qutob
Journal: Clin Rev Allergy Immunol Date: 2016-02 Impact factor: 8.667

Review 2. Advances in mechanisms of asthma, allergy, and immunology in 2008.

Authors: Joshua A Boyce; David Broide; Kenji Matsumoto; Bruce S Bochner
Journal: J Allergy Clin Immunol Date: 2009-03 Impact factor: 10.793

3. Cutaneous sarcoidosis in a patient with severe asthma treated with omalizumab.

Authors: Samuel Yung; Duhyun Han; Jason K Lee
Journal: Can Respir J Date: 2015-09-24 Impact factor: 2.409

Review 4. Churg-Strauss syndrome: 2005-2008 update.

Authors: Rafael G Grau
Journal: Curr Rheumatol Rep Date: 2008-12 Impact factor: 4.592

5. Omalizumab in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA): single-center experience in 18 cases.

Authors: Zeynep Celebi Sozener; Begum Gorgulu; Dilsad Mungan; Betul Ayse Sin; Zeynep Misirligil; Omur Aydin; Sevim Bavbek
Journal: World Allergy Organ J Date: 2018-12-03 Impact factor: 4.084

6. Anti-cytokine targeted therapies for ANCA-associated vasculitis.

Authors: Malgorzata M Bala; Teresa J Malecka-Massalska; Magdalena Koperny; Joanna F Zajac; Jarosław D Jarczewski; Wojciech Szczeklik
Journal: Cochrane Database Syst Rev Date: 2020-09-29

Review 7. Adrenal insufficiency is a contraindication for omalizumab therapy in mast cell activation disease: risk for serum sickness.

Authors: G J Molderings; F L Dumoulin; J Homann; B Sido; J Textor; M Mücke; G J Qagish; R Barion; M Raithel; D Klingmüller; V S Schäfer; H J Hertfelder; D Berdel; G Tridente; L B Weinstock; L B Afrin
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2020-05-06 Impact factor: 3.000

7 in total